Allergy Therapeutics PLC Annual Report and Accounts (3117N)
October 24 2016 - 8:35AM
UK Regulatory
TIDMAGY
RNS Number : 3117N
Allergy Therapeutics PLC
24 October 2016
24 October 2016
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Annual Report and Accounts
Allergy Therapeutics (AIM:AGY), the fully integrated
pharmaceutical company specialising in allergy vaccines, announces
that the Annual Report and Accounts for the year ended 30 June 2016
are available on the Company's website in the Investor Relations
section. They can be located at:
www.allergytherapeutics.com/media/1241/allergytherapeutics_ra_15-16.pdf
Printed copies of the Annual Report and Accounts for the year
end 30 June 2016 were posted to shareholders on 22 October 2016,
together with the Notice of the Annual General Meeting.
ENDS
For further information, please contact:
Allergy Therapeutics
+44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer
Nick Wykeman, Finance Director
Panmure Gordon
+44 (0) 20 7886 2500
Freddy Crossley / Duncan Monteith, Corporate Finance
Tom Salvesen, Corporate Broking
Consilium Strategic Communications
+44 20 3709 5700
Mary-Jane Elliott / Ivar Milligan / Matthew Neal / Laura
Thornton
allergytherapeutics@consilium-comms.com
Note to editors:
About Allergy Therapeutics
Allergy Therapeutics is an international specialty
pharmaceutical company focussed on the treatment and diagnosis of
allergic disorders including immunotherapy vaccines that cure
disease. The Company sells proprietary products and third party
products from its subsidiaries in nine major European countries and
via distribution agreements in an additional ten countries.
Formed in 1999 out of Smith Kline Beecham, Allergy Therapeutics
is headquartered in Worthing, UK with MHRA-approved manufacturing
facilities. The Company employs c.420 employees and is listed on
the London Stock Exchange (AIM:AGY). For more information, please
see www.allergytherapeutics.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSBDBDGSXDBGLS
(END) Dow Jones Newswires
October 24, 2016 08:35 ET (12:35 GMT)
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024
